Form 8-K - Current report:
SEC Accession No. 0001140361-19-023019
Filing Date
2019-12-23
Accepted
2019-12-20 18:35:12
Documents
19
Period of Report
2019-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 48220
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 821592
6 image01.jpg GRAPHIC 2298
7 image02.jpg GRAPHIC 2929
8 image03.jpg GRAPHIC 2801
9 image04.jpg GRAPHIC 3086
10 image05.jpg GRAPHIC 2484
11 image06.jpg GRAPHIC 3913
  Complete submission text file 0001140361-19-023019.txt   1176152

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20191219.xsd EX-101.SCH 4198
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20191219_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20191219_pre.xml EX-101.PRE 16832
18 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4062
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 191303103
SIC: 2834 Pharmaceutical Preparations